GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 6.607
NA - Nord America 6.307
AS - Asia 2.077
AF - Africa 96
OC - Oceania 59
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.198
Nazione #
US - Stati Uniti d'America 6.259
GB - Regno Unito 1.809
IT - Italia 1.429
CN - Cina 1.367
IE - Irlanda 633
FR - Francia 574
SE - Svezia 540
RU - Federazione Russa 534
SG - Singapore 415
DE - Germania 376
FI - Finlandia 354
UA - Ucraina 119
TG - Togo 72
TR - Turchia 67
AU - Australia 52
ES - Italia 40
NL - Olanda 37
HK - Hong Kong 36
JP - Giappone 34
IN - India 31
CA - Canada 29
BR - Brasile 27
BE - Belgio 26
IR - Iran 22
KR - Corea 21
CH - Svizzera 20
PL - Polonia 19
MX - Messico 16
CZ - Repubblica Ceca 14
MY - Malesia 13
DK - Danimarca 12
AT - Austria 11
CL - Cile 11
ID - Indonesia 10
EG - Egitto 8
PH - Filippine 8
RO - Romania 8
SA - Arabia Saudita 8
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
VN - Vietnam 7
DZ - Algeria 6
HR - Croazia 6
IL - Israele 6
PT - Portogallo 6
IS - Islanda 5
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
LK - Sri Lanka 4
MA - Marocco 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
CO - Colombia 3
EU - Europa 3
LT - Lituania 3
LV - Lettonia 3
NO - Norvegia 3
AM - Armenia 2
EC - Ecuador 2
JO - Giordania 2
LU - Lussemburgo 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AR - Argentina 1
AZ - Azerbaigian 1
BZ - Belize 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 15.198
Città #
Southend 1.591
Chandler 1.055
Jacksonville 952
Dublin 622
Woodbridge 551
Ann Arbor 431
Ashburn 428
Houston 428
Singapore 258
Beijing 244
Wilmington 220
Lawrence 215
Princeton 215
Jinan 131
Nanjing 129
Milan 114
New York 114
Shenyang 97
Sindelfingen 93
Verona 87
Rome 75
Helsinki 73
Lomé 72
Hebei 63
Haikou 53
Washington 48
Tianjin 46
Seattle 45
Nanchang 44
Changsha 43
Redwood City 42
Guangzhou 37
Hangzhou 34
Dallas 33
Zhengzhou 33
Jiaxing 32
Boardman 31
Bologna 31
Falls Church 29
Hong Kong 29
Kent 29
Los Angeles 28
Ningbo 28
Chicago 27
Redmond 27
Brussels 25
Esslingen am Neckar 25
Venice 23
Fairfield 22
Taizhou 22
Lappeenranta 21
Norwalk 21
Seoul 19
Turin 19
Sydney 18
Düsseldorf 17
Dongguan 16
Florence 16
Lancaster 16
Fuzhou 15
London 15
Naples 15
Amsterdam 14
Tokyo 14
Genoa 13
Kuala Lumpur 13
Enfield 12
Madrid 12
Moscow 12
Taiyuan 12
Bari 11
Brescia 11
Palermo 11
Phoenix 11
Vicenza 11
Atlanta 10
Frankfurt am Main 10
Shanghai 10
Toronto 10
Catania 9
Edinburgh 9
Lanzhou 9
Perth 9
San Jose 9
Trieste 9
Vienna 9
Canberra 8
Mersin 8
Pescara 8
Warsaw 8
Almaty 7
Cagliari 7
Copenhagen 7
Las Rozas de Madrid 7
Nova Iguaçu 7
Santiago 7
Zurich 7
Cairo 6
Casaloldo 6
Council Bluffs 6
Totale 9.691
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 572
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 325
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 300
Dietary supplements for lipedema 205
Il ruolo della vitamina D nella dermatite atopica 119
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 107
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 105
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 103
Impact of TNF-α antagonists on the quality of life in selected skin diseases 103
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 102
Squamous cell carcinoma arising in lupus vulgaris. 101
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 101
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 100
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 98
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 98
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 98
Vitamin D levels in patients with psoriasis with or without arthritis 98
Polymorphisms, diet and nutrigenomics 97
Severe impairment of quality of life in Hailey-Hailey disease. 96
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 94
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 92
Retention rate of systemic drugs in patients with chronic plaque psoriasis 89
Lebbra lepromatosa. 87
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 86
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 85
Psoriasis, the liver, and the gastrointestinal tract 84
The expectations of patients with psoriasis during an office consultation 84
Heat urticaria: a revision of published cases with an update on classification and management 83
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 82
Targeting TNF-a in psoriasis and psoriatic arthritis. 82
Psoriasis and the metabolic syndrome 82
Pimecrolimus in dermatology: atopic dermatitis and beyond. 81
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 81
Incidence of respiratory and allergic symptoms in Italian and immigrant children 81
Attitude to treatment of patients with psoriasis attending SPA center 81
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 80
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 80
Advanced Glycation End Products in the Pathogenesis of Psoriasis 80
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 79
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 79
Psoriasi. Una guida per una migliore gestione del paziente. 78
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 78
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 78
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 78
Acneiform eruption induced by cetuximab 77
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 76
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 76
The diagnostic and therapeutic challenge of early psoriatic arthritis 75
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 74
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 74
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 74
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 74
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 74
Complicanze dell'obesità: la cute 73
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 73
The metabolic syndrome in psoriasis 73
The importance of treating mild atopic dermatitis. 72
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 72
Image Gallery: Pyoderma gangrenosum of the penis. 72
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 72
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 71
Hyperuricaemia in patients with chronic plaque psoriasis. 71
Dermatite atopica. 70
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 70
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 70
PSORIASIS 70
Effects of secukinumab on serum adipocytokines: preliminary data 70
Chronic plaque psoriasis is associated with increased arterial stiffness 69
Metabolic comorbidities and psoriasis. 69
Autoimmune progesterone dermatitis. 68
Vitamin D status in patients with chronic plaque psoriasis 68
L’organo pelle: struttura, biologia, funzioni. 68
Biologic therapies in psoriasis: a new therapeutic approach 68
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 67
Psodisk, a new visual method for assessing the burden of psoriasis on patients. 66
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 66
Systemic therapy of psoriasis in diabetic patients 66
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 66
Le malattie della mucosa orale 65
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 65
Targeting tumor necrosis factor a in the therapy of psoriasis. 65
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 65
Microcircolatory modifications of psoriatic lesions during topical therapy. 64
Immunoregulation of allergic contact dermatitis. 63
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 63
Usefulness of the Framingham risk score in patients with chronic psoriasis 63
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. 63
Concept of Remission in Chronic Plaque Psoriasis 63
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 63
Aggiornamento sulla terapie biologiche della psoriasi 61
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. 61
La dermatite atopica nella seconda infanzia ed adolescenza 61
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 61
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 60
Considerations for Systemic Treatment of Psoriasis in Obese Patients 60
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 60
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 59
Phenotypes of atopic dermatitis 59
Cardiometabolic comorbidities: the fingerprint of psoriasis 59
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. 59
Totale 8.768
Categoria #
all - tutte 63.107
article - articoli 60.864
book - libri 244
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.999
Totale 126.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.190 0 0 0 120 104 206 142 98 104 147 98 171
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20251.060 386 349 230 95 0 0 0 0 0 0 0 0
Totale 15.534